SCHEMBL24565774

SCHEMBL24565774

CC(C)(C)C(=O)Nc1cc(Cl)nn(CCOCc2ccccc2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MITF O75030 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ KLF5 Q13887 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ NR3C1 P04150 1/20 0.40
▸ CFTR P13569 1/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ NPY2R P49146 1/20 0.37
▸ PTGER1 P34995 3/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ GRN P28799 2/20 0.37
▸ SORT1 Q99523 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24565775 0.84 KCNJ6 (0.41) SMN1; SMN2KDM4EMITFALDH1A1HPGD
SCHEMBL24007634 0.73 KDM4E (0.44) SMN1; SMN2KDM4EMITFALDH1A1HPGD
SCHEMBL799063 0.69 PPARA (0.47) SMN1; SMN2ALDH1A1NR3C1NPSR1GAA
SCHEMBL11899889 0.69 GRN (0.73) KDM4EALDH1A1NPSR1GAAGRN
SCHEMBL25594884 0.68 PPARA (0.45) NR3C1JAK2PTGER1CYP2C9HDAC3
SCHEMBL25599482 0.67 PPARA (0.44) NR3C1JAK2PTGER1CYP2C9
SCHEMBL24007902 0.67 KDM4E (0.41) SMN1; SMN2KDM4EMITFALDH1A1HPGD
SCHEMBL798561 0.66 GRN (0.49) ALDH1A1TDP1NR3C1GAAGRN
SCHEMBL20661034 0.66 HPGD (0.44) SMN1; SMN2KDM4EALDH1A1HPGDNR3C1
SCHEMBL799021 0.66 GAA (0.44) SMN1; SMN2ALDH1A1HPGDTDP1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140527-A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. (US) 2022-06-30 — — WO disclosed
Send feedback